Filana Therapeutics Statistics
Total Valuation
FLNA has a market cap or net worth of $71.98 million. The enterprise value is -$14.59 million.
Important Dates
The last earnings date was Thursday, May 7, 2026, before market open.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FLNA has 48.31 million shares outstanding. The number of shares has increased by 1.39% in one year.
| Current Share Class | 48.31M |
| Shares Outstanding | 48.31M |
| Shares Change (YoY) | +1.39% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.05% |
| Owned by Institutions (%) | 28.42% |
| Float | 47.32M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.06 |
| P/TBV Ratio | 1.06 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.19
| Current Ratio | 2.19 |
| Quick Ratio | 2.16 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -79.59% and return on invested capital (ROIC) is -31.72%.
| Return on Equity (ROE) | -79.59% |
| Return on Assets (ROA) | -24.91% |
| Return on Invested Capital (ROIC) | -31.72% |
| Return on Capital Employed (ROCE) | -72.78% |
| Weighted Average Cost of Capital (WACC) | 0.07% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.90M |
| Employee Count | 20 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.62% in the last 52 weeks. The beta is -0.76, so FLNA's price volatility has been lower than the market average.
| Beta (5Y) | -0.76 |
| 52-Week Price Change | -25.62% |
| 50-Day Moving Average | 1.54 |
| 200-Day Moving Average | 2.36 |
| Relative Strength Index (RSI) | 55.02 |
| Average Volume (20 Days) | 420,379 |
Short Selling Information
The latest short interest is 6.69 million, so 13.85% of the outstanding shares have been sold short.
| Short Interest | 6.69M |
| Short Previous Month | 6.85M |
| Short % of Shares Out | 13.85% |
| Short % of Float | 14.14% |
| Short Ratio (days to cover) | 19.04 |
Income Statement
| Revenue | n/a |
| Gross Profit | -17.47M |
| Operating Income | -49.67M |
| Pretax Income | -77.90M |
| Net Income | -77.90M |
| EBITDA | -48.71M |
| EBIT | -49.67M |
| Earnings Per Share (EPS) | n/a |
Full Income Statement Balance Sheet
The company has $86.57 million in cash and n/a in debt, with a net cash position of $86.57 million or $1.79 per share.
| Cash & Cash Equivalents | 86.57M |
| Total Debt | n/a |
| Net Cash | 86.57M |
| Net Cash Per Share | $1.79 |
| Equity (Book Value) | 68.14M |
| Book Value Per Share | n/a |
| Working Capital | 47.85M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -29.79M |
| Capital Expenditures | -581,000 |
| Depreciation & Amortization | 950,000 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FLNA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.39% |
| Shareholder Yield | -1.39% |
| Earnings Yield | -108.23% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for FLNA is $6.50, which is 336.24% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.50 |
| Price Target Difference | 336.24% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 10, 2017. It was a reverse split with a ratio of 1:7.
| Last Split Date | May 10, 2017 |
| Split Type | Reverse |
| Split Ratio | 1:7 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |